Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids

Annals of Plastic Surgery

Volumn 43, Issue 2, 1999, Pages 179-184

  Lee, Thomas Y ^a   Chin, Gyu S ^a   Kim, William J H ^a   Chau, Dorothy ^a   Gittes, George K ^a   Longaker, Michael T ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; COLLAGEN SYNTHESIS; HUMAN; HUMAN TISSUE; KELOID; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR FORMATION;

EID: 0032777216     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-199943020-00013     Document Type: Article

References (36)

1. McCoy BJ, Cohen IK. Effects of various sera on growth kinetics and collagen synthesis by keloid and normal dermal fibroblasts. Plast Reconstr Surg 1981;67(4):505-510
2. Peacock Jr EE, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J 1970;63(7):755-760
3. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998;4(1): 19-24
4. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993;8(1):1-9
5. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991;88(15):6642-6646
6. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991;324(14):933-940 [See comments]
7. Border WA, Noble NA. Transforming growth factor-beta in glomerular injury. Exp Nephrol 1994;2(1):13-17
8. Border WA, Noble NA, Ketteler M. TGF-beta: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int Suppl 1995;49:S59-S61
9. Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 1997;51(5):1388-1396
10. Zhang K, Garner W, Cohen L, et al. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol 1995;104(5):750-754
11. Garner WL, Karmiol S, Rodriguez JL, et al. Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J Invest Dermatol 1993;101(6):875-879
12. Gruschwitz M, Muller PU, Sepp N, et al. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 1990;94(2):197-203
13. Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 1991;97(2):240-248
14. Babu M, Diegelmann R, Oliver N. Keloid fibroblasts exhibit an altered response to TGF-beta. J Invest Dermatol 1992;99(5):650-655
15. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996;98(5):827-833
16. Smith PD, Siegler K, Wanf X, Robson MC. Transforming growth factor beta 2 increases DNA synthesis and collagen production in keloid fibroblasts. Surg Forum 1998;49: 617-619
17. Smith P, Mosiello G, Maggi SP, et al. TGF-beta activates proliferative scar fibroblasts [abstract]. Wound Rep Regen 1998;6:A264
18. Polo M, Ko F, Busillo F, et al. The 1997 Moyer Award. Cytokine production in patients with hypertrophic burn scars. J Burn Care Rehabil 1997;18(6):477-482
19. Polo M, Kim YJ, Wang X, et al. Effects of exogenous TGF-beta2 on human proliferative scar xenografts in nude rats. Surg Forum 1997;48:669-671
20. Polo M, Kim YJ, Kucukcelebi A, et al. An in vivo model of human proliferative scar. J Surg Res 1998;74(2):187-195
21. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108(Pt. 3):985-1002
22. Wu L, Siddiqui A, Morris DE, et al. Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies. Arch Surg 1997;132(7):753-760
23. Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989;9(4):1642-1650
24. Nakajima H, Kishi T, Tsuchiya Y, et al. Exposure of fibroblasts derived from keloid patients to low-energy electromagnetic fields: preferential inhibition of cell proliferation, collagen synthesis, and transforming growth factor beta expression in keloid fibroblasts in vitro. Ann Plast Surg 1997;39(5):536-541
25. Chau D, Mancoll JS, Lee S, et al. Tamoxifen downregulates TGF-beta production in keloid fibroblasts. Ann Plast Surg 1998;40(5):490-493
26. Yamada H, Tajima S, Nishikawa T, et al. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem (Tokyo) 1994;116(4):892-897
27. Tredget EE, Shankowsky HA, Pannu R, et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 1998;102(5):1317-1328 Plast Reconstr Surg 1998;102(5):1329-1330 [Discussion]
28. Tredget EE, Shankowsky HA, Pannu R, et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 1998;102(5):1317-1328 Plast Reconstr Surg 1998;102(5):1329-1330 [Discussion]
29. Bascom CC, Wolfshohl JR, Coffey Jr RJ, et al. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratin-ocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol 1989;9(12):5508-5515
30. Longaker M, Bohana K, Harrison M, et al. Scarless healing in the fetus: possible role for inflammatory macrophages and TGF-b isoforms. Wound Rep Regen 1994;2:104-112
31. Kischer CW. Comparative ultrastructure of hypertrophic scars and keloids. Scanning Electron Microsc 1984;(Pt. 1):423-431
32. Steinbrech D, Mehrara B, Chau D, et al. Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg 1999; 42:514-520
33. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6(7): 1899-1904
34. Edwards DR, Leco KJ, Beaudry PP, et al. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 1996;31(1-2):207-223
35. Overall CM, Wrana JL, Sodek J. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Connect Tissue Res 1989; 20(1-4):289-294
36. Mignatti P. Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney Int Suppl 1995;49:S12-S14.